The CDC Group invests $21mn to the Asian Institute of Medical Sciences (AIMS)

By Catherine Sturman
With ambitions to develop businesses across Africa and Asia, boost the number of employment roles and improve local economies, The CDC Group has recentl...

With ambitions to develop businesses across Africa and Asia, boost the number of employment roles and improve local economies, The CDC Group has recently placed significant investment in healthcare provider Asian Institute of Medical Sciences (AIMS)

Established in 1948, the CDC remains the UK’s oldest Development Finance Institution (DFI) and is solely owned by the UK government. Investing up to US$21mn will see the Group work to improve present healthcare services across India, as well as support the development of a five-year hospital expansion into tier 2 and 3 cities in Jharkhand, Bihar and Uttar Pradesh.

The project will see the creation of up to 2,000 new healthcare roles, provide room for up to a thousand new hospital beds at existing facilities and guarantee essential medical training for staff members.

See also

''We're pleased to be able to support a healthcare company that will reach patients that currently have to travel many hours to large cities like Delhi and Calcutta to receive the treatment they need,” commented Srini Nagarajan, managing director and head of South Asia for CDC.

“Our investment in Asian will increase access to high quality care in poorer and under-served cities in Northern and Central India. It will also create many jobs and training opportunities in these cities.”

With three tertiary care hospitals, two secondary hospitals and three health clinics, AIMS has received both NABH and NABL accreditation, with the aim to continually meet the needs of its patients through the use of digital tools and innovative solutions. This is only complemented further through its specialities in cardiology, oncology, orthopaedics and more.

''At Asian, we firmly believe that quality healthcare is a basic need and it needs to be delivered closer to where there is need and not only in big metropolitan centres. We already have our footprint in tier 2 and tier 3 towns. Our association with CDC is going to support us in expanding our services further in states like UP, Bihar and Jharkhand,'' added founder of AIMS N K Pandey.


Featured Articles

Creating robust pharma supply chains with delivery devices

John Swift, Head of Supply Chain at Owen Mumford Pharmaceutical Services, discusses how lifecycle management is key to a safe supply of pharma products

From Ukraine to Myanmar, reports reveal attacks on hospitals

Reports from the Centre for Information Resilience shows Russian army attacked Ukrainian hospitals & Myanmar’s military Junta targeted medical facilities

The use of AI in biopharma according to L.E.K. Consulting

L.E.K. Consulting’s Stephen Roper & Anne Dhulesia discuss the use of AI in biopharma and unleashing the power of Big Data in the healthcare sector

Novartis Kisqali minimises breast cancer recurrence

Medical Devices & Pharma

Rimidi CEO Lucienne Marie Ide on improving patient outcomes


WatchGuard Technologies & cybersecurity in healthcare